Research Center on Managed Care and Drug Abuse Treatment

描述(由申请人提供)： 在这份关于布兰迪斯/哈佛管理医疗和药物滥用治疗中心的修订续订申请中，我们建议继续布兰迪斯大学施耐德卫生政策研究所和哈佛医学院卫生保健政策系之间的合作。我们建议该中心继续使用基本相同的多学科研究小组。我们扩大了通过中心核心提供的临床、统计和方法学专业知识，以及我们将技术转让作为核心职能的重点。我们建议将该中心的主题从对管理性医疗的一般性关注细化为第二代研究，这些研究考察了以下问题：在管理性医疗环境中，组织、管理、融资和支付的哪些要素对有效的药物滥用服务提供产生了影响？特别是，如何利用这些领域内的激励措施来鼓励或支持提供高质量的药物滥用治疗服务？围绕这一主题，我们规划了两个项目和一个试点项目，简要介绍如下： 员工团体的药物滥用途径。这项研究将使用管理健康网络(MI-IN)的索赔资格、授权和初始评估数据来调查集成EAP/MBHC和独立组件产品在物质滥用使用率和成本方面是否存在差异。还将对通过MHN接受药物滥用治疗的参与者进行调查。 行为卫生保健中的概况和激励。这项研究评估了提供者概况和激励措施对提高护理质量的贡献。结合准实验性中断时间序列和随机对照设计，该研究使用了康涅狄格州管理性行为卫生保健计划下接受药物滥用治疗的低收入一般援助客户的现有数据。 试点：平等立法对药物滥用治疗的影响。这项试点将探索对加州私人医疗保险增加药物滥用治疗平价福利的增量影响进行大规模研究的可行性。

DESCRIPTION (provided by applicant): In this revised renewal request for the Brandeis / Harvard Center on Managed Care and Drug Abuse Treatment, we propose to continue the collaboration between Brandeis University's Schneider Institute for Health Policy and Harvard Medical School's Department of Health Care Policy. We propose that the Center continue with largely the same multidisciplinary group of researchers. We have expanded the clinical, statistical, and methodological expertise available through the Center Core, as well as our emphasis on technology transfer as a core function. We propose to refine the Center's theme from a generic focus on managed care to a second generation of studies that examine the question: What elements of organization, management, financing and payment in a managed care environment make a difference in effective drug abuse service delivery? In particular, how can incentives within these areas be used to encourage or support the provision of quality drug abuse treatment services? With this theme we have planned two projects and a pilot described briefly below: Substance Abuse Pathways for Employee Groups. The study will use claims eligibility, authorization, and initial assessment data from Managed Health Network (MI-IN) to investigate whether there are differences in substance abuse utilization and costs between integrated EAP/MBHC and stand-alone component products. A survey of enrollees who are both users and nonusers of substance abuse treatment through MHN will also be conducted. Profiling and Incentives in Behavioral Health Care. This research evaluates the contribution of provider profiling and incentives to improve the quality of care. Combining a quasi-experimental interrupted time series and randomized-controlled designs, the study uses existing data from low-income general assistance clients who receive substance abuse treatment under the state of Connecticut's managed behavioral health care program. Pilot: The Effect of Parity Legislation on Substance Abuse Treatment. This pilot will explore the feasibility for a large-scale study of the incremental impact of adding a substance abuse treatment parity benefit to private health insurance in California.